Citigroup analyst Samantha Semenkow maintains argenx (NASDAQ:ARGX) with a Buy and raises the pric

Boston Common Asset Management LLC bought a new position in argenex SE (NASDAQ: ARGX) in the first q

Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr

SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI company building a computer-aided design suit

Here is how argenex SE (ARGX) and Cardinal Health (CAH) have performed compared to their sector so f

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably alrea

RBC Capital analyst Luca Issi maintains argenx (NASDAQ:ARGX) with a Outperform and raises the pri

This profitable Netherlands-based biotech name has produced triple-digit quarterly earnings growth.

B of A Securities analyst Tazeen Ahmad maintains argenx (NASDAQ:ARGX) with a Buy and raises the p

Live Updates Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. S

Argenx SE (NASDAQ:ARGX) stock has faced pressure after the company disclosed changes to the analysis

HC Wainwright sees over $1 billion in sales potential for Argenx's Vyvgart in IMNM despite myosi

HC Wainwright & Co. analyst Douglas Tsao reiterates argenx (NASDAQ:ARGX) with a Buy and maint

Argenx stock reversed course Wednesday, bumping above its 21-day line, as investors digested its myo

Top Wall Street analysts changed their outlook on top names. See all analyst rating changes, includi

Morgan Stanley analyst Matthew Harrison maintains argenx (NASDAQ:ARGX) with a Overweight and rais

argenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn Leadership in Autoimmune Myositis Transcr

Executives at argenex NASDAQ: ARGX told investors at a Goldman Sachs healthcare event that they cont

Wedbush analyst David Nierengarten reiterates argenx (NASDAQ:ARGX) with a Outperform and maintain

Sanofi discontinues Phase 3 riliprubart study for CIDP due to low efficacy. SNY stock ticks up. Read

Sanofi scrapped a final-phase study Wednesday of an experimental CIDP treatment. The stock tumbled i

argenx stock rises nearly 9% in a month after the FDA expands Vyvgart's gMG label, opening treatment

argenx SE (ARGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider

Argenx (ARGX) witnessed a jump in share price last session on above-average trading volume. The late

argenx NASDAQ: ARGX Chief Financial Officer Karl Gubitz told investors at the 46th Annual William Bl

Wedbush analyst David Nierengarten reiterates argenx (NASDAQ:ARGX) with a Outperform and maintain

argenx SE ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the liv

ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvemen

Wells Fargo analyst Derek Archila maintains argenx (NASDAQ:ARGX) with a Overweight and raises the

May 28, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology comp

May 27, 2026Amsterdam, the Netherlands - argenx (Euronext and Nasdaq: ARGX), a global immunology com

Evercore ISI Group analyst Gavin Clark-Gartner maintains argenx (NASDAQ:ARGX) with a Outperform a

Argenx shares rise after FDA expands VYVGART approval to all adult gMG patients, widening the drug&#

VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult pa

Guggenheim analyst Yatin Suneja maintains argenx (NASDAQ:ARGX) with a Buy and raises the price ta

Wells Fargo analyst Derek Archila maintains argenx (NASDAQ:ARGX) with a Overweight and raises the

argenx (NASDAQ:ARGX) reported quarterly earnings of $5.52 per share which beat the analyst consensus

argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovator committed to improving the li

Viridian shares fall after Amgen TEPEZZA Phase 3 data shows stronger efficacy, raising concerns over

U.S. stock futures are up early Monday morning, following a mixed week that saw rotation out of expe